NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) informs about its scheduled company presentations for March and April 2020.
Since the Board of Directors of NeuroVive Pharmaceutical AB on Wednesday, 19 February, 2020 decided to propose a preferential rights issue with a subscription period from 6 April, 2020 until 24 April, 2020, the Company wishes to provide information about upcoming company presentations by NeuroVive in March and April 2020.
NeuroVive’s CEO Erik Kinnman will present the company and its business at the following events. For more information, follow the links indicated below.
Wednesday 11 March: Stockholm Corporate Finance 12th Life Science seminar 2020, Stockholm
Berns (Kammarsalen), Berzelii park, at 07.30 a.m. – 12.15 p.m.
https://stockholmcorp.se/stockholm-corporate-finance-12e-life-science-seminarium/
Thursday 12 March: Bolagsdag, Erik Penser Bank, Stockholm
Erik Penser Bank, Apelbergsgatan 27, at 10.00 a.m. – approx. 6.00 p.m.
Register to bolagsdag@penser.se no later than 9 March
Tuesday 31 March: Redeye Digital Investor Forum, Stockholm
Redeye, Mäster Samuelsgatan 42, at 1.00 p.m. – 3.00 p.m.
https://www.redeye.se/events#/event/585691
Tuesday 21 April: Redeye Investor After Work, Gothenburg
Scandic Rubinen, Kungsportsavenyn 24, at 5.30 p.m. – 9.00 p.m.
https://www.redeye.se/events#/
For information about the Company and the preferential rights issue, two interviews with NeuroVive’s CEO Erik Kinnman are available:
- BioStock (in Swedish): https://www.biostock.se/2020/02/neurovives-vd-om-den-kommande-emissionen/
- Redeye (in English): https://www.redeye.se/research/585670/neurovive-interview-ceo-erik-kinnman-video